REVIEW ARTICLE
N-acetylcysteine in acute cardiology: 10 years later
What do we know and what would we like to know?!
Jan Sochman, MD, PhD*,*
* Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Manuscript received April 16, 2001;
revised manuscript received January 17, 2002,
accepted February 8, 2002.
* Reprint requests and correspondence: Dr. Jan Sochman, Intensive Care Unit, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Prague 4, Czech Republic. jan.sochman{at}medicon.cz
N-acetylcysteine (NAC) is known in a variety of branches of medicine. This paper addresses in detail the action of NAC as it is emerging from research and clinical trials over the past decade in cardiology, giving rise to new concepts. The result is a process resembling creation of a mosaic from individual pieces. Also, the role of NAC in acute cardiology, during acute reperfusion in particular, is defined.
|
Abbreviations and Acronyms
| | GISSI | | Gruppo Italiano per lo Studio della Streptochinasi nell Infarto Miocardico study | | GUSTO | | Global Utilization of Streptokinase and T-PA for Occluded Coronary Artery trial | | ISIS | | International Study of Infarct Survival | | ISLAND | | Infarct Size Limitation: Acute N-acetylcysteine Defense trial | | MPG | | mercaptopropionyl glycine | | NAC | | N-acetylcysteine | | -SH | | sulfhydryl groups |
|
This article has been cited by other articles:

|
 |

|
 |
 
T.-M. Lee, P.-Y. Lai, and N.-C. Chang
Effect of N-acetylcysteine on sympathetic hyperinnervation in post-infarcted rat hearts
Cardiovasc Res,
September 16, 2009;
(2009)
cvp286v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. U. Nigwekar and P. Kandula
N-Acetylcysteine in Cardiovascular-Surgery-Associated Renal Failure: A Meta-Analysis
Ann. Thorac. Surg.,
January 1, 2009;
87(1):
139 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. El-Hamamsy, L.-M. Stevens, M. Carrier, M. Pellerin, D. Bouchard, P. Demers, R. Cartier, P. Page, and L. P. Perrault
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial
J. Thorac. Cardiovasc. Surg.,
January 1, 2007;
133(1):
7 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Usatyuk, N. L. Parinandi, and V. Natarajan
Redox Regulation of 4-Hydroxy-2-nonenal-mediated Endothelial Barrier Dysfunction by Focal Adhesion, Adherens, and Tight Junction Proteins
J. Biol. Chem.,
November 17, 2006;
281(46):
35554 - 35566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bourraindeloup, C. Adamy, G. Candiani, M. Cailleret, M.-C. Bourin, T. Badoual, J. B. Su, S. Adubeiro, F. Roudot-Thoraval, J.-L. Dubois-Rande, et al.
N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor-{alpha} Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats
Circulation,
October 5, 2004;
110(14):
2003 - 2009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Robinson
Renal Disease, Homocysteine, and Cardiovascular Complications
Circulation,
January 27, 2004;
109(3):
294 - 295.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cailleret, A. Amadou, N. Andrieu-Abadie, A. Nawrocki, C. Adamy, B. Ait-Mamar, F. Rocaries, M. Best-Belpomme, T. Levade, C. Pavoine, et al.
N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-{alpha} on Calcium Transients and Contraction in Adult Rat Cardiomyocytes
Circulation,
January 27, 2004;
109(3):
406 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|